Interleukin-4 (IL4) and IL-13 exert similar, nonadditive effects on endothelial cells, inducing vascular cell adhesion molecule-1 (VCAM-1) expression and subsequent transmigration of eosinophils. The receptor for IL-4 and IL-13 was described as a shared heteromultimeric complex in which the common y-chain (yc) subunit was essential for activity. Endothelial cells bound both cytokines with high affinity; by flow cytofluorometry and reverse transcription-polymerase chain reaction (RT-PCR), they expressed IL-4 receptor a (IL4Ra) but did not express the yc of the IL-2R. Radioligand cross-linking experiments followed by immunoprecipitation with the monoclonal antibody (MoAb) S697 to the IL-4% showed IL4-specific binding at 130 kD, the IL4Ra, and to a minor extent to a double band coimmunoprecipitated at 65 to 75 kD. ['26111L-13 bound predominantly to the 65-to 75-HE PREFERENTIAL ACCUMULATION of very late The IL-13R has been proposed as an additional candidate using the y c as part of the receptor c0mp1ex.l~ There is convincing evidence that yc is not binding IL-4 by itself, although it associates with the 130-kD IL4R and enhances its affinity with the ligand.l3.I6.l7
The IL-13R has been proposed as an additional candidate using the y c as part of the receptor c0mp1ex.l~ There is convincing evidence that yc is not binding IL-4 by itself, although it associates with the 130-kD IL4R and enhances its affinity with the ligand.l3.I6.l7
IL-4 and IL-13 have remarkably similar functions on different leukocytic cells." The observation that different cell lines, although expressing distinct surface receptors for IL-4 and IL-13, share common receptor subunits supports these Sharing of yc on most cells adds additional complexity to the understanding of the IL-4/IL-l3R biology and raises the question whether the yc is required for signal transduction.
In this study, we have characterized the receptor for IL-4 and IL-13 on endothelial cells. Based on the observation that endothelial cells do not express y c , our data suggest a heterodimeric receptor complex exists that consists of IL4Ra and a yet unknown 65-to 75-kD protein shared by IL-4 and IL-13. This receptor configuration allows clear separation of the IL-13-binding protein at 65 to 75 kD from the yc that is of similar molecular mass.
MATERIALS AND METHODS

Reagents.
The Chinese hamster ovary-derived human IL-13 and a mutant form of human IL-4, IL-4 Y 124D, were kindly provided by Dr G. Zurawski (DNAX Research Institute of Cellular and Molecular Biology, Palo Alto, CA). We acknowledge the generous supply of human IL-1 by Dr P.T. Lomedico (Hoffmann-La Roche, Nutley, NJ) and of tumor necrosis factor (TNF) by Dr Z. Nagy (Preclinical Research, Sandoz Ltd, Basel, Switzerland). Purified human IL-4 (10' U/mg) produced in Chinese hamster ovary cells and the monoclonal antibodies (MoAbs) S697 and S103 were a gift of Dr J. Banchereau the IL-2RP chain." In these experiments the MoAb specifically precipitated a protein with a molecular mass of 65 to 70 kD, which corresponds to that of the yC? ' Genistein, staurosporine, H7, herbimycin A, tyrphostin A46 and A47, wortmannin, and okadaic acid (Calbiochem, San Diego, CA) were either diluted in medium or in dimethyl sulfoxide (DMSO) and used at indicated concentrations using final concentrations of DMSO at 1:lOOO (vol/vol). Sodium-orthovanadate was purchased from Sigma, and disuccinimidyl suberate was from Pierce (Rockford, IL).
Human umbilical vein endothelial cells (HUVECs) were harvested as previously described. immunofluorescence with rabbit antihuman factor antibody (Ab)." ECV304, a spontaneously transformed immortal endothelial cell line established from the vein of a normal umbilical cord, and HU-VEC-C were from American Type Culture Collection (Rockville, MD). They were cultivated in minimum essential medium-cy containing 10% fetal calf serum (FCS). In contrast to HUVECs, they did not express VCAM-1 in response to IL-4 or IL-13. The human colorectal cell line LS513 (a gift from Dr L. Suardet, ISREC, Epalinges, Switzerland) was cultured in a 1:l mixture of Dulbecco's modified Eagle's medium (DMEM) and Ham's F-12 nutrient solution (GIBCO, Basel, Switzerland) containing 10% FCS. The mast cell line HMC-1 was from D r J. Butterfield (Rochester, MN). The gibbon T-cell line MLA144 was from American Type Culture Collection. The B16 cells, a mouse fibroblast cell line, transfected with the human IL-4Ra cDNA, were received from Dr J. Banchereau
Cell cultures.
(Schering Plough, Dardilly, France). All these adherent cells were kept in DMEM containing 10% FCS. The nonadherent cells were grown in RPMI 1640 (Amimed, Allschwil, Switzerland) containing 10% FCS. All media were supplemented with 2 mmoVL L-glutamine, 100 U/mL penicillin, and 100 pg/mL streptomycin. Standard culture procedures (Myco Tect; GIBCO) consistently showed the cell lines to be free of mycoplasma contamination.
Granulocytes were separated from 400 mL of heparinized (20 U/mL blood; Novo Industries, Copenhagen, Denmark) whole blood from normal individuals, by methocel-metrizoate sedimentation followed by buoyant density centrifugation over Ficoll-Paque (Pharmacia, Uppsala, Sweden) as previously de~cribed.'~ The resulting sediment, essentially free of monocytes and lymphocytes, contained mostly neutrophils (96% to 99%) and eosinophils (1 % to 4%). Eosinophils were further enriched by negative selection using CD16 immunomagnetic beads according to the method of Hansel et alz5 and were cultured overnight in Iscove's medium containing 10% FCS, 10 pmom recombinant human granulocyte-macrophage colony-stimulating factor (Sandoz Ltd, Basel, Switzerland), and 10 pmoVL recombinant IL-3 (Sandoz Ltd) as described.'" Determination of the transendothelial migration of eosinophils. Bilayer vascular constmcts consisting of extracellular matrix from human fibroblast that were covered by confluent HUVEC monolayersz3 were preincubated with IL-4 andlor IL-13 at indicated concentrations for 16 hours at 37°C. washed twice with Hanks' balanced salt solution, and coincubated for 2 hours together with 2 X l@ eosinophils resuspended in 500 pL of DMEM containing 10% FCS. Transendothelial migration was determined as de~cribed.~"" Briefly, after fixation of the bilayers with 1% paraformaldehyde in phosphate-buffed saline (PBS), the transmigrated eosinophils were counted in a blinded fashion in 3 arbitrarily chosen high power fields I n i t -
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Fluorescence Intensity human IL-4Ra. y e , and the human and mouse &-microglobulin were custom-synthesized and quality-checked by capillary electrophoresis by MWG-Biotech (Ebersberg, Germany). The human and mouse &microglobulin primers were as described."." The human sense primer was 5'-CCAGCAGAGAATGGAAAGTC-3'. and the antisense primer was 5'-GATGCTGCTTACATGTCTCG-3' spanning a 268-bp fragment; mouse sense primer was S-TGACCGGCT-TGTATGCTATC-3' and antisense primer was 5'-CAGTGTGAG-CCAGGATATAG-3' spanning a 222-bp fragment. The human IL4-Ra sense primer was 5'-GGAAGAGGGGTATAAGCCTIT-3', and the antisense primer was Y-CACGGAGACAAAGTCAC-GAT-3' spanning a 571-bp fragment; the yc sense primer was 5'-GAGCAAGCGCCATGTTGAA-3'. and the antisense primer was Tris-buffered saline for 5 minutes at room temperature and was centrifuged at 10,000g for 2 minutes at 4°C. The cell pellet was solubilized for 40 minutes on ice in 50 p L lysis buffer containing 2% (vollvol) NP-40. 0.1% (wtlvol) EDTA. and I pg/mL aprotinin. leupeptin. pepstatin. and phenylmethyl sulfonyl fluoride. After centrifugation for 15 minutes at l0.0OOg. the supernatant was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions using 3% to 10% (wt/vol) polyacrylamide gels. Autoradiography was performed at -70°C exposing x-ray Hyperfilms (Amersham International) for 2 to 3 weeks.
For immunoprecipitation. the cell lysates were cleared with denatured pansorbin (Calbiochem, San Diego, CA) that had been labeled with control IgG for 30 minutes. After incubation with specific antibody-labeled pansorbin for 14 hours, the precipitates were For washed several times with lysis buffer, eluted with reducing PAGEloading buffer at 96°C. and centrifuged (2,000~ for 2 minutes), and the supernatant was subjected to the 3% to 10% SDS-PAGE.
RESULTS
Biological effects of IL-4 and IL-13 on endothelial cells. IL-4 and IL-13 have similar effects on HUVECs in culture,
augmenting the adherence of VLA-4-expressing cell^.^.^ IL-4-induced adherence resulted in subsequent transendothelial migration of eosinophils through the bilayer vascular construct.'" We show that IL-13 evokes transendothelial migration of eosinophils similarly to IL-4 and that IL-4 and IL-13 exert no additive effects (Fig 1) . Similar nonadditive effects were obtained at different suboptimal concentrations of IL-4 and IL-13 (data not shown). However, HUVECs were more sensitive to IL-4 than to IL-13. Half-maximal transendothelial migration was observed at 0.06 t 0.01 nmol/L IL-4 and at 0.9 t 0.3 nmol/L for IL-13 (n t SEM of three experiments).
Flow cytofluorometric analysis of IL-4-activated HU-VEC monolayers showed significant induction of VCAM-I , with up to 65% immunopositive cells (Fig 2) . The responding population expressing detectable VCAM-1 was variable among the different HUVEC batches. Such variability was recently reported.30 VCAM-1 induction peaked at 16 hours and lasted for at least 72 hours of IL-4 stimulation (data not shown). When HUVECs were exposed to IL-13, VCAM-1 expression was essentially the same, and the population of immunopositive HUVECs was comparable (Fig 2) . The time dependence obtained with IL-13 was identical to that of IL-4 (data not shown). Preincubation of the monolayers with both cytokines neither enhanced the level of VCAM-1 expression nor enlarged the population of VCAM-1 -positive cells. However, clear cooperation was observed when either IL-4 or IL-13 was combined with TNF (Fig 2) . Similar results were obtained with IL-l instead of TNF (data not shown).
Mutant IL-4 substituted at TyrIz4 for Asp (IL4Y124D), which is known to bind to the lL-4Ra.'*." did not induce VCAM-1 and, when preincubated in a 100-fold excess, competitively antagonized VCAM-I induction by native IL-4 and IL-13 (Fig 3) . These data indicate a shared signaling subunit in the IL-4 and IL-13 receptor complex. For personal use only. on November 11, 2017. by guest www.bloodjournal.org From press the IL-4Ra, though at a low density (8.4 2 1.2 specific fluorescence units; n 5 SEM of five experiments). Similar expression of IL-4Ra was detected on adult saphenous vein endothelial cells (data not shown), MLA-144; a gibbon Tcell line; and HMC-1, a human mast cell line (Fig 4) . B16, a mouse fibroblast cell line stable transfected with the human IL-4Ra cDNA, was used as a positive control.
The 7, of the IL-2R has been thought to be an obligate component of the IL4R, forming an heteromultimeric complex including the IL-4Ra chain." We studied the expression of yE on the above listed cell types using TUGh4, a rat MoAb directed against recombinant human yC.= Both cell lines, MLA-144 and HMC-1, were clearly y-chain-positive. However, HUVECs (Fig 4) and adult saphenous vein endothelial cells (data not shown) did not express detectable levels of y=.
Receptor-binding analysis of radiolabeled IL-4 and IL-13 to the HUVEC line ECV304. Binding of radiolabeled IL-4 and IL-13 to HUVECs and analysis of the data by the weighted least-square curve-fitting methodz9 showed one class of binding sites for both cytokines (Fig 5) . These data showed for IL-4 a kd value of 33. No' yc transcripts were detected with an extensive range of 25 to 35 PCR cycles (Fig 6) . A strong IL-4Ra-specific signal and no detectable message for yc in the IL-4Ra-transfected mouse B16 cells were employed as positive and negative controls, respectively.
Radioligand cross-linking of the IL-4 and IL-I3 receptor complex on HWECs. To investigate the subunit structure of the endothelial IL-4/IL-13 receptor complex iodinated IL-4 or IL-13 was cross-linked by the disuccinimidyl suberate method to its functional binding sites on the cell surface. The interacting subunits were analyzed by SDS-PAGE calculating the net molecular masses of the ligand-cross-linked receptors by subtraction of the 19-kD IL-4 or the 15-kD IL-13 (Fig 7a) . The majority of ['251]IL-4 was cross-linked at the 130-kD protein, whereas a double band was detected at 65 to 75 kD. Different traces of radioactivity were also detected at higher molecular weights. The [1251]IL-13 predominantly cross-linked to a protein migrating at 65 to 75 kD. A trace amount of radioactivity bound at the 130-kD level, presumably to the IL-4Ra (Fig 7a) . (Fig 7a) .
Immunoprecipitation of the ['2sI]IL-4-cross-linked membrane proteins with the IL-4Ra MoAb S697 and subsequent SDS-PAGE analysis yielded the predicted binding pattern, a predominant band at 130 kD and minor bands at 65 to 75 kD (Fig 7b) . No activity was found at the 200-kD protein that presumably consisted of chemically cross-linked aggregates of the two subunits. In cross-linking experiments with ['z51]IL-13, the MoAb S697 was unable to precipitate any visible activity (data not shown). As with control IgG, the MoAb TUGh4 against yc failed to precipitate any labeled IL-4 (Fig 7b) and IL-13 (data not shown) . The finding that IL-13 did not bind to the transfected B 16 cells solely expressing the 130-kD IL-4Ra chain supports the hypothesis of a specific IL-13-binding subunit (Fig 7c) (Fig 8) . At such high concentrations genistein hqs been shown to inhibit tyrosine kinases and protein kinase C. 34 In the endothelial cells a selective action of genistein was considered to be likely, because TNF-induced VCAM-1 expression was still intact. The IL-4 and IL-13 signals were not inhibited by high concentrations of staurosporine (0.1 pmol/L). The lack of inhibition by staurosporine indicates that protein kinase C is not directly involved in the IL-4 and IL-13-mediated signaling (data not shown). Several highly specific and potent tyrosine kinase inhibitors, tyrphostin A47, B46 (1 pmoVL), and wortmannin (10 pmol/L) had no effect. Furthermore, neither the tyrosine phosphatase inhibitor orthovanadate nor okadaic acid, a serindthreonine phosphatase inhibitor, blocked endothelial VCAM-1 induction. 
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In immunofluorescence studies, we observed clonal expression of VCAM-1 in response to IL-4 (unpublished observation) leading to focal adherence and transendothelial migration of eosinophils." Regardless whether HUVECs were exposed to IL-4, IL-13, or both, the VCAM-1 -expressing population was of the same size and of comparable intensity. Moreover, IL-4 and IL-13 possess a similar capacity to evoke transendothelial migration of eosinophils. However, on a molar basis HUVECs were about 15 times more sensitive to IL-4.
Binding studies with the HUVECs and ECV304, a transformed cell line derived from HWECs, showed a single class of binding sites with similar high affinity for IL-4 (~3 0 pmol/L) and IL-13 (=60 pmoVL). In the experiments with HUVECs, IL-4 and IL-13 bound to approximately 200 and 700 sites per cell, respectively. COS-3 and A431 cells are reported to have an IL-4 affinity of -20 pmoVL?' whereas T lymphocytes express two receptor populations, one with a kd value of = l o 0 pmoVL and a second with low binding affinity.'6 These variable affinities may account for differences in the receptor configuration. The affinity of IL-13 on COS-3 and A431 cells was -300 pmoVL.*' These investigators reported that IL-13, after iodination of the single tyrosine (Tyr4'), almost completely lost its bioactivity. Therefore, they used a modified form of IL-13 (Phe431L-13-GYGY) that was suitable to be iodinated by the chloramin T method." In our study IL-13 was labeled by the iodogen method that completely maintained the activity of native IL-13. The same procedure has also been successfully used by others.'' This directly labeled IL-13 bound to the HWECs and ECV304 with an affinity comparable with that of IL-4.
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In radioligand cross-linking experiments with different cell lines, the iodinated IL-4 consistently labeled proteins at 220, 145, and 70 kD; whereas IL-13 was cross-linked only to two proteins at 220 and 70 kD." By this technique, endothelial cells showed a banding pattern in which IL-4 was predominantly cross-linked to IL-4Ra, with a net molecular mass of -130 kD, and to a minor yet unknown protein migrating at 65 to 75 kD. IL-13 bound predominantly to the 65-to 75-kD protein, although a minor band was observed at 130 kD, presumably the IL-4Ra. There was no radioactive band identified at 220 kD. Supporting the data obtained with different cell lines,'8,20 high concentrations of cold IL-4 completely displaced labeled IL-13 from its binding to the HUVECs. Despite of the fact that the majority of radiolabeled IL-4 was removed by cold 1L-13, a trace amount of labeled IL-4 was still detectable at 130 kD. On different cell lines, the capacity of cold IL-13 to remove labeled IL-4 was highly variable." Such cross-competition of TL-4 and E-13 has been suggested to result from ligation of shared subunits of a multimeric receptor complex that varies in its configurat i~n . "~'~ Supportive of this model is our finding that, in IL-4 cross-linking experiments, the anti-IL-4Ra MoAb S697 was able to coprecipitate both the 130-kD and the 65-to 75-kD band. S697 did not, however, precipitate visible bands from IL-13 -cross-linked endothelial cells, and IL-4Ra-transfected B16 cells did not bind labeled IL-13. Together, our data suggest that there is a weak association between the IL-4Ra and the IL-13-binding subunit and no intimate contact between IL-13 and the IL-4Ra.
The IL-4R and the IL-7R were initially described as single-chain receptors.38339 Very recently the y-chain of the IL-2R has been described as a common subunit, slightly increasing the affinity of these receptors for their respective ligand^.'^.'^.'^ Although the yc associates with the 130-kD IL4R, it does not directly bind IL-4. Moreover, these studies have inferred a function for the yc in signal transduction. It has been proposed that the IL-13R uses the yc as a receptor s~b u n i t . '~. '~, '~ Indeed, most of the cell lines involved in IL-4 and IL-13 receptor studies contained the y c , including those that responded to IL-13. In contrast, we show that human endothelial cells do not express yc on their surface and that no message was found at the mRNA level with sensitive RT-PCR. Very recently, a mouse plasmacytoma cell line B940*41 and a human renal carcinoma cell line4* were reported to respond to IL-4 and IL-13 in the absence of detectable y c . Herein, we first show in differentiated, nontransformed cells a heterodimeric configuration of the IL-4AL-13 receptor lacking yc. The nonsignaling mutant IL-4Y 124D bound efficiently to this receptor complex, blocking the IL-13-mediated response. These data, together with the recent finding that IL-13 induces tyrosine phosphorylation of the IL-4Ra,43,w suggest a heterodimeric receptor complex in which the IL-4Ra is the signaling subunit.
An important function of the IL-4/IL-13 receptor complex is induction of VCAM-I. In a recent publication, IL-4 was found to be a weak and variable inducer of VCAM-1.'' Therefore, these investigators used the protein kinase Cactivating phorbol myristate acetate as costimulatory agent, showing that herbimycin A partially inhibits the IL-4-induced VCAM-1 e x p r e s~i o n .~~
In our experiments IL-4 and IL-13 induced a variable but significant number of HUVECs to express VCAM-1 without phorbol myristate acetate costimulation. Whether the culture conditions, ie, the use of human serum and/or the use of highly purified human fibronectin as a growth-promoting matrix protein, may be responsible for this improved response to IL-4 and IL-13 remains to be clarified. Regardless of that functional difference, our data support kinase-transduced effects of IL-4 and IL-13 showing total inhibition of VCAh4-1 induction by genistein and herbimycin A.
The heterodimeric receptor complex shared by IL-4 and IL-13 on human endothelial cells clearly signals in the absence of the IL3R yc, suggesting greater specificity of ycmediated events than hitherto assumed.
